Eli Lilly & Co. (LLY) Tops Q1 EPS by 21c, Raises FY EPS Guidance

Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.34, $0.21 better than the analyst estimate of $1.13. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.49 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2018 EPS of $5.10-$5.20, versus the consensus of $4.88.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.

You May Also Be Interested In

• Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
• Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance
• Fermi Inc. (FRMI) Reports Q2 Loss of $0.04